PNC-27 – 10mg Targeted Peptide

Comprehensive Laboratory Profile

The acquisition of targeted, membrane-active chimeric peptides provides institutional laboratories with the advanced capability to observe localized cellular disruption and protein interactions in real-time. By integrating the PNC-27 10mg peptide into institutional protocols, researchers gain access to a highly purified formulation engineered specifically to simulate targeted transmembrane pore formation.

Synthesized within the USA to the most rigorous industry standards, this specialized complex delivers absolute analytical precision. Utilizing the PNC-27 10mg formulation ensures your laboratory acquires reproducible data, free from the performance variability of improperly isolated or degraded research materials.

Biochemical Profile: Chimeric Penetratin Construct

The PNC-27 formulation is a synthetically engineered chimeric peptide. It consists of a specific domain of the p53 protein (residues 12-26) physically conjugated to a transmembrane-penetrating sequence known as penetratin.

By introducing the PNC-27 10mg matrix into an in-vitro environment, researchers can evaluate its highly specific binding affinity. Unlike traditional intracellular pathways, this peptide selectively binds to HDM2 (the human homolog of MDM2) when it is aberrantly expressed on the outer cellular membrane of specific anomalous cell lines, a phenomenon not observed in healthy, homeostatic cell models.

Mechanism of Action in Cellular Assays

When introduced to cellular monolayers or complex tissue cultures expressing membrane-bound HDM2, the PNC-27 10mg compound functions as an aggressive structural disruptor. Upon targeted binding to the membrane-localized receptors, the peptide undergoes a profound conformational change, embedding itself into the lipid bilayer.

This interaction directly initiates the formation of robust transmembrane pores. The resulting breach in cellular structural integrity causes a rapid, unchecked influx of extracellular fluid. By deploying this formulation, laboratories can document the aggressive stimulation of osmotic swelling and subsequent targeted cellular necrosis. This allows researchers to establish highly stable micro-environments where targeted membrane degradation can be monitored with total scientific clarity without impacting surrounding non-target cells.

Primary In-Vitro Research Applications

The exceptional purity and targeted chimeric design of this peptide make it a cornerstone for advanced structural and protein-interaction R&D:

• Targeted Necrosis Assays: Mapping the kinetic response and breakdown rates of cellular membranes exposed to pore-forming sequences.

• MDM2 Membrane Localization: Evaluating the precise binding efficiency of the p53 domain to anomalously expressed surface receptors.

• Osmotic Swelling Modeling: Utilizing the PNC-27 10mg complex to monitor the rate of transmembrane fluid influx and cellular lysis.

• Chimeric Delivery R&D: Using this specific penetratin construct to establish standardized laboratory models for comparative efficacy testing of intracellular vs. membrane-active delivery.

Absolute Purity and Quality Assurance

At Ion Peptides, we recognize that anomalous data caused by degraded or structurally compromised substrates critically jeopardizes institutional research funding. Every single batch of our PNC-27 10mg peptide is subjected to uncompromising third-party analytical testing before being approved for acquisition.

We utilize High-Performance Liquid Chromatography (HPLC) to verify a purity threshold of >99.0%. Furthermore, rigorous Mass Spectrometry (MS) confirms the precise structural sequence, ensuring the correct conjugation of the p53 domain to the penetratin tail. By securing your supply through our secure USA synthesis network and encrypted crypto gateways, you guarantee your facility receives elite, uncompromised materials.

Lyophilization, Storage, and Reconstitution Protocols

To ensure maximum molecular stability during secure domestic transit, the PNC-27 10mg vial is supplied as a lyophilized (freeze-dried) solid powder.

• Storage: Keep vials in a climate-controlled, dark environment, ideally at or below -20°C. Protected from light and moisture, the unmixed powder remains stable for up to 36 months.

• Reconstitution: Utilize sterile bacteriostatic water.

  1. Allow the vial to reach ambient room temperature to prevent condensation.

  2. Introduce the diluent slowly, directing the fluid flow down the inner wall of the glass to prevent sheer stress.

  3. Do not agitate or vortex the vial. Allow the PNC-27 10mg powder to dissolve naturally into a clear solution via gentle swirling.

  4. Once reconstituted, refrigerate immediately at 2°C to 8°C and utilize within standard laboratory protocol timelines.